Blog
About

  • Record: found
  • Abstract: found
  • Article: found

IGF-1 Therapy in Children with Liver Dysfunction

,

Journal of Medical Research and Innovation

Biomedical Research and Therapy

Read this article at

ScienceOpenPublisher
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Human growth and development occur as a result of numerous processes which gets initiated under the influence of endocrine hormones. Insulin-like growth factor 1 (IGF-1) plays a most pivotal role in the growth and organ development of a child. IGF-1 is a peptide that belongs to somatomedins group of hormones, also known as somatomedin C. It releases from the liver and other tissues under the influence of growth hormone (GH). The liver is the main protagonist source of IGF-1 hence any disease that can cause liver dysfunction will eventually lead to growth impairment. During the period of growth regulation with GH therapy in liver disease and/or post liver transplantation, the persistent deficiency of IGF-1 proves to be a big challenge to therapy. Growth hormone therapy together with IGF-1 infusion can lead to good results on growth. Therefore, it is important to focus on IGF- level in serum along with Growth hormone while treating a child with poor growth in chronic liver disease and after liver transplantation. The role of IGF-1 therapy should also be considered for better growth and development.

      Related collections

      Author and article information

      Journal
      Journal of Medical Research and Innovation
      J Med Res Innov
      Biomedical Research and Therapy
      2456-8139
      April 16 2017
      January 08 2017
      : 1
      : 1
      : 12-16
      10.15419/jmri.10
      © 2017

      Comments

      Comment on this article